Abercrombie’ Peak Holiday Period Hit By Inventory Receipt Slides; Post-Holiday Sales Trend Accelerates
Abercrombie & Fitch Co (NYSE:ANF) expects fiscal 2021 sales growth of 19% – 20% year-on-year and up 2% – 3% compared…
21 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from NYSE regarding delayed Form 20-F filing.
Telsey Advisory Group Maintains Outperform on Abercrombie & Fitch, Lowers Price Target to $45
Telsey Advisory Group analyst Dana Telsey maintains Abercrombie & Fitch (NYSE:ANF) with a Outperform and lowers the price target from $55 to $45.
5 Stocks To Watch For January 11, 2022
Some of the stocks that may grab investor focus today are:
Wall Street expects TD SYNNEX Corporation (NYSE: SNX) to report quarterly earnings at $2.67 per share on revenue of $14.25 billion before the opening bell. TD SYNNEX shares slipped 0.1% to $109.70 in after-hours trading.
Abercrombie & Fitch Sees Prelim. FY21 Net Sales Up 19-20% From 2020, Sees Q4 Net Sales Up 4-6% From 2020
NEW ALBANY, Ohio, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Abercrombie & Fitch Co. (NYSE:ANF) today provided an update on its outlook for the 2021 fiscal year and the fourth quarter of fiscal 2021.
For Fiscal 2021 the
UBS Downgrades Abercrombie & Fitch to Neutral, Lowers Price Target to $37
UBS analyst Jay Sole downgrades Abercrombie & Fitch (NYSE:ANF) from Buy to Neutral and lowers the price target from $68 to $37.
56 Biggest Movers From Yesterday
Gainers
Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
